Viking Therapeutics (VKTX) Reports In-Line Q2 EPS

July 28, 2021 4:34 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.20), in-line with the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities